Home Medical News U.S. health regulator approves Teva's migraine drug

U.S. health regulator approves Teva's migraine drug


September 14, 2018 / 10:33 PM / Updated 8 minutes ago

U.S. health regulator approves Teva's migraine drug

(Reuters) – Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine treatment, a key drug the company has been banking on to help revive its fortunes.

A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. REUTERS/Ammar Awad/File Photo

The world’s largest generic drugmaker had hoped to receive approval for the injectable drug, fremanezumab, by June. Its release was delayed due to U.S. regulatory concerns about the manufacturing process at the South Korean plant of its development partner Celltrion.

Around 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation, making for a large market that has attracted several drugmakers.

Reporting by Tova Cohen in Tel AviV, Deena Beasley in Los Angeles and Saumya Joseph in Bengaluru; Editing by Bill Berkrot

Source link

Previous articlePrimary Care Shortage Growing Across U.S.
Next articlePhysicians, Entrepreneurs Call for Stark Law Scaleback
Dr Irfanullah Khan Born: 15th July,1994 in Khagram,Dir Upper KPK Pakistan. Others names:Doctor Irfo,Peshoo Education:Pharm-D Scholar Graduated from Abasyn University Peshawar. Occupation:Clinical Pharmacist,Doctor,Entrepreneur. Home Town:Dir Upper Height: 6 feet. Website:Iukmedonline.com


Please enter your comment!
Please enter your name here